UMEWF yields 487.80% · JNJ yields 2.13%● Live data
📍 UMEWF pulled ahead of the other in Year 1
Combined, UMEWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of UMEWF + JNJ for your $10,000?
UMeWorld Limited, together with its subsidiaries, operates as an educational technology company with a focus on the K-12 education market in China. It offers UMFun, a cloud-based assessment and learning analytics platform that analyzes and adapts to a student's performance and personalizes the delivery of proprietary educational items in accordance with the student's learning needs. The company's platform provides standards-based instruction, practice, assessments, and productivity tools that enhance the performance of educators and students. Its products also enable educators to track student performance in real-time to address individual student learning gaps while allowing administrators to monitor student progress and measure teacher effectiveness. It serves schools, teachers, students, and parents through online and mobile platforms. The company was formerly known as AlphaRx, Inc. and changed its name to UMeWorld Limited in March 2013. UMeWorld Limited was incorporated in 1997 and is based in Causeway Bay, Hong Kong.
Full UMEWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.